Normal human raplA and 35A raplA (which-encodes a protein with a Thr-35--Ala mutation) were cloned into a baculovirus transfer vector and expressed in SfO insect cells. The resulting proteins were purified, and their nucleotide binding, GTPase activities, and responsiveness to GTPase-activating proteins (GAPs) taining Gly-12-*Val and Gln-61--Lys mutations, there is still an interaction between GAP and the GTP-bound forms of these proteins (50).
activities by both recombinant proteins were lower than that observed with the neutrophil Rapl, but the GTPase activity of the neutrophil and wild-type recombinant Rapl proteins could be stimulated to similar levels by Rap-GAP activity in neutrophil cytosol. In contrast to wild-type RaplA, the GTPase activity of 35A
Rap was unresponsive to Rap-GAP stimulation. Neither recombinant RaplA nor neutrophil Rapl protein GTPase activity could be stimulated by recombinant Ras-GAP at a concentration 25-fold higher than that required to hydrolyze 50% of H-Ras-bound GTP under similar conditions. These results suggest that the putative effector domains (amino acids 32 to 40) shared between Rapl and Ras are functionally similar and interact with their respective GAPs. However, although Rapl and Ras are identical in this region, secondary structure or additional regions must confer the ability to respond to GAPs. ras gene products are membrane-associated proteins with molecular weights of approximately 21,000 that bind and hydrolyze GTP (for reviews, see references 2 and 8) . The cellular function of these proteins has yet to be established. However, overexpression or mutation of ras causes transformation of cultured fibroblasts, and mutated Ras proteins have been detected in a number of human tumors. Transforming mutations decrease the intrinsic GTPase activity of Ras or decrease the affinity of the protein for guanine nucleotides. Both changes favor formation of the active, GTP-bound form of Ras in vivo (C.J.D., unpublished data). Introduction of additional mutations that prevent membrane localization of Ras blocks its ability to induce cellular transformation (51) . Thus, analogous to the signal-transducing G proteins (13) , ras gene products appear to be active in a GTP-bound state, are localized to the plasma membrane, and probably interact with other membrane-bound proteins.
Amino acid substitutions between residues 32 and 40 have been shown to destroy the transforming potential of ras (43, 52) . Therefore, this region of Ras has been postulated to interact with an effector molecule of Ras in a biological pathway. While the intrinsic GTPase activity of Ras is low, it is stimulated 100-fold by a cytosolic protein (GTPaseactivating protein; GAP) (46) . The point mutations in the ras effector region that block the transforming potential of Ras also block the ability of GAP to stimulate GTP hydrolysis (1, 6, 27, 50) . It therefore seems likely that GAP interacts with this site and may be an effector of Ras function. This notion is supported by the observation that although GAP does not stimulate the GTPase activity of transforming proteins con-taining Gly-12-*Val and Gln-61--Lys mutations, there is still an interaction between GAP and the GTP-bound forms of these proteins (50) .
Over the past 5 years, a 20-to 30-member superfamily of ras-related proteins has been discovered by protein purification and molecular cloning techniques. These proteins include the R-Ras (22) , Ral (7), Rab (45), Rho (25) , Rac (10) , and Rap (19, 21, 34, 35) families. Unique GAPs have been identified for ras (1, 6, 12)-, rhoA (12)-, and rapl (20, 49) , and it is likely that each family interacts with specific GAPs. The rapl gene products (RaplA and Rap1B) are of particular interest because the putative effector and/or GAP interaction domain of Rapl is identical to that of H-Ras, K-Ras, N-Ras, and R-Ras. High expression of raplA mRNA has been correlated with reversion of viral K-ras-transformed mouse fibroblasts (and thus raplA has also been called Krev-1 [21] ). Therefore, although Rap GTPase activity is stimulated by its own GAP(s), it has been speculated that Rap might reverse cellular transformation by competing with Ras for Ras-GAP. Rapl has been demonstrated to be a substrate for cyclic AMP-dependent protein kinase in vitro and in vivo (16, 18, 28 ; G.M.B. and L.A.Q., Biochem. J., in press). However, in vitro phosphorylation had no effect on the ability of purified Rap protein to bind or hydrolyze guanine nucleotides (16, 28; G.M.B. and L.A.Q., in press).
We used the baculovirus expression system (23, 45) (3, 000 Ci/mmol), and [,y-32P]GTP (10 to 50 or 6,000 Ci/mmol) were from Dupont, NEN Research Products. Purified recombinant Ras-GAP was prepared as already described (47) . Rapl from human neutrophil membranes was purified as previously described (G.M.B. and L.A.Q., in press). The neutrophil protein was determined to be Rapl by N-terminal amino acid sequencing, reactivity with anti-Rap antibodies R52-1 and R64-1, and phosphorylation by cyclic AMP-dependent protein kinase (G.M.B. and L.A.Q., in press). Sf9 cells were from Max Summers (44) and were grown as previously described (33) . All other materials were as reported elsewhere (4, 5; G.M.B. and L.A.Q., in press).
Molecular cloning and oligonucleotide-directed mutagenesis of the raplA gene. A 35-amino-acid N-terminal sequence was obtained from a purified 22-kilodalton GTP-binding protein isolated from human neutrophil membranes (5) . Two synthetic oligonucleotides corresponding to the amino acid sequence were used to screen a dimethyl formamide-differentiated human promyelocytic leukemia (HL60) cell X gtll cDNA library (37) . A 1.3-kilobase EcoRI fragment was obtained from a clone that was positive with both probes and subcloned into M13mpl8 for dideoxy sequencing (38) and oligonucleotide-directed mutagenesis (9, 53) . The predicted amino acid sequence produced by the gene was identical to that subsequently reported for RaplA (34) , Krev-1 (21), and smg-p21 (19) . The coding and noncoding DNA sequences were identical to those of Krev-1, except for a single-base change which did not alter the amino acid sequence.
An A-*T base change was introduced at codon 6 to generate a HindIII site without altering the amino acid sequence. An A-*G base change was subsequently made in codon 35 to create a Thr--Ala mutation. A 0.7-kilobase-pair HindIII-BglII fragment of 35A raplA containing codons 6 to 184 and the 3'-untranslated region was swapped with codons 6 to 189 of H-ras in the pATras bacterial expression vector (9) . Expression of raplA was induced with isopropyl-B-D-thiogalactopyranoside in Escherichia coli PR13Q, with maximal protein yield at 6 to 8 h postinduction. The 0.7-kilobase-pair HindIII-BglII raplA fragment was also subcloned into the KpnI-BglII sites of the pAcC12 baculovirus vector polylinker. Complementary synthetic 18-base (CAAA TATGCGGGAATACA) and 26-base (AGCTTGTATTCC CGCATATTTGGTAC) oligonucleotides were annealed together to generate 5' KpnI and 3' HindIll sticky ends to complete the raplA sequence (codons 1 to 5) and to enable initiation of the coding sequence 52 base pairs downstream from the original polyhedron protein initiation site. pAcC12 was derived from pVL941 (24) by deleting the unique EcoRI site at 7.15 kilobases and introducing a polylinker sequence (GGTACCCGGGCTGCAGAATTCTAGATCTCGAGCT CCATGGTGGATCC) at the unique BamHI insertion site. Generation and isolation of a recombinant virus expressing 35A raplA was performed essentially as described by Summers and Smith (44) . A HindIII-EcoRI fragment encoding WT raplA residues 6 to 184 was also synthetically generated, as will be described elsewhere (K. Zhang and D. R. Lowy, unpublished data) and was introduced into the pAcC12 vector as described above. This construct was used for expression of WT 35A RaplA was similarly purified from a 500-ml suspension culture by DEAE-Sephacel (110-ml column) and heptylamine-Sepharose chromatographies.
Guanine nucleotide binding and GTPase activity. To determine the Kd value for GTP-yS binding to RaplA protein, 2 pmol of purified RaplA was incubated with 25 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; pH 8.0)-i mM dithiothreitol-0.09% lubrol PX and various concentrations of GTP-yS (25,000 cpm/pmol) in 10 mM MgCl2 or an excess of EDTA (0.25 mM MgCl2, 4 mM EDTA). Incubations were for 5 min without or 120 min with Mg2+ (at which point equilibrium binding was achieved) and were terminated by addition of 2 ml of stop mixture (25 mM Tris hydrochloride [pH 8.0], 100 mM NaCl, 30 mM MgCl2, 2 mM dithiothreitol, 1 mg of bovine serum albumin per ml). Nonspecific binding was determined by performing experiments with unlabeled GTPyS at a concentration 500 times the Kd; these values were then subtracted from the total binding. Binding to RaplA was quantitated by vacuum filtration on BA-85 nitrocellulose filters and liquid scintillation counting (29) . For nucleotide competition curves, GTPyS binding was performed at 50 mM, which was the Kd value for the nucleotide in MgCl2. RaplA (2 pmol) was incubated as described above with 50 nM GTP-yS (200,000 cpm/pmol) in the indicated concentrations of unlabeled GTP or GDP, and the samples were processed as described previously. GTPase activity was determined as already described (36) For studies with Ras-GAP, the concentrations of GTP and GTP-bound protein were decreased 30-fold and GTP of higher specific activity (6,000 Ci/mmol) was used. Reactions were terminated by addition of 2 ml of the ice-cold nucleotide-binding stop mixture. The amount of protein-bound GTP was determined by nitrocellulose filtration.
Miscellaneous. Cell lysate and cytosol protein concentrations were determined by the Pierce BCA assay. Purified protein concentrations were determined with amido black (41) . Western blotting (immunoblotting) was performed as already described (15) , with 125I-labeled goat anti-rabbit immunoglobulin G as the second antibody. The primary antisera were raised against peptides representing RaplA amino acids 118 to 129 (R52-1) or 127 to 137 (R64-1) essentially as already described (4) and did not cross-react with the low-molecular-weight GTP-binding proteins, ADPribosylation factor (ARF), H-Ras, Aplysia Rho, Rac, or neutrophil G24K. There was no immunoreactivity of R64-1 with lysates of Sf9 cells infected with wild-type virus. (Fig. 1, lanes 2 and 3) . The identities of these proteins were confirmed with polyclonal antisera (R52-1 and R64-1) raised against peptides unique to the Rapl sequence (lanes 4 to 7). Following extraction of total cell protein in 0.9%o sodium cholate and sequential chromatography on DEAE-Sephacel, Ultragel AcA44, and heptylamine-Sepharose, recombinant WT RaplA was purified to approximately 90% homogeneity with just one significant contaminant (Fig. 1, lane 9) . A 4.5-mg quantity of GTPyS-binding activity was recovered from 19 mg of activity in the cholate extract, and approximately 30% of the purified protein bound guanine nucleotides. 35A RaplA was partially purified by the same approach but without the AcA44 gel filtration step (Fig. 1, lane 3) . (Fig. 2C) . No significant differences in the off rates of GTP and GDP from WT RaplA were observed in millimolar Mg2+, and little nucleotide release occurred over a 100-min incubation period (Fig. 3A) . Without Mg2+, the rate of release of GDP was rapid (Fig. 3C) . However, the dissociation rate of GTP was extremely slow, with a tl,2 of 50 min. Similar results were obtained with purified neutrophil Rapl ( Table 1) .
RESULTS
Stimulation of Rap GTPase activity by cytosolic GAP. The basal GTPase activity of the recombinant WT RaplA protein was approximately 0.0005 min-' compared with 0.01 min-' for neutrophil Rapl (Table 1) . However, the rate of GTP hydrolysis by WT RaplA was stimulated by neutrophil cytosol in a dose-and time-dependent manner (65 ,ug of cytosol protein hydrolyzed greater than 90% of the Raplbound GTP in 15 min (data not shown). A concentration of cytosol that promoted 50% hydrolysis of Rapl-bound GTP in a 5-min assay was routinely used to remain within the linear region of the activity curve, and this rate was similar to that achieved by neutrophil Rapl with cytosol ( Fig. 4A and B) . The ability of cytosol to increase the rate of loss of proteinbound 32P04-was not due to enhanced nucleotide ex-VOL. 10 (Fig. 2B) . However, without Mg2+, 35A raplA had a much reduced affinity for GTP (560 + 64 nM; Fig. 2D ). Similarly to the analogous mutation in Ras (6) ability of the GTPase activity of the resulting protein to be stimulated by Rap-GAP (Fig. 4C) .
No stimulation of Rap GTPase activity by Ras-GAP. Since the putative effector site of Ras (amino acid residues 32 to 40) is completely conserved in Rapl, it was of interest to determine whether Rapl GTPase activity could be stimulated by Ras-GAP. Recombinant Ras-GAP, at a concentration of 370 ng/ml, stimulated hydrolysis of 50% of Ras-bound GTP during 5 min of incubation and hydrolyzed more than 90% of the bound GTP at a concentration of 1.85 ,ug/ml (Fig.  5) . However, Ras-GAP was unable to stimulate the GTPase activity of recombinant or neutrophil Rapl protein when incubated with concentrations of up to 10 ,ug/ml. A 25-,ug sample of cytosol was used as a positive control.
DISCUSSION
We produced recombinant human RaplA protein in Sf9 insect cells by using the baculovirus expression system. The biochemical properties of WT RaplA and a putative effector site mutant, 35A RaplA, were characterized and compared with those of human neutrophil Rapl. The level of expression of Rapl was relatively high in human neutrophils (at least 0.2% of membrane protein). However, to obtain an abundant source of RaplA that was readily separable from other Ras-related GTP-binding proteins (including the raplB and rap2 gene products) for biochemical analysis, it was necessary to generate a source of recombinant protein. We found that expression of raplA by using the baculovirus system was advantageous because, in contrast to bacterially produced protein, the RaplA produced by Sf9 cells was both soluble and biochemically active. Overall, the similar biochemical properties of insect cell-expressed and neutrophilderived proteins demonstrated the benefits of the baculovirus expression system for isolation of recombinant RaplA protein.
An advantage of the baculovirus system is that insect cells perform many of the posttranslational modifications of proteins characteristic of mammalian cells (23) . Sf9 cell RaplA migrated as a doublet on polyacrylamide gels, and the lower band, which comigrated with neutrophil membrane Rapl, has been shown to be carboxyl methylated, farnesylated, and translocated to the plasma membrane, similar to the mammalian protein (J. E. Buss, L. A. Quilliam, K. Kato, P. J. Casey, P. A. Solski, G. Wong, R. Clark, F. McCormick, G. M. Bokoch, and C. J. Der, submitted for publication). Palmitoylation of H-Ras has also been described recently in Sf9 cells (31) , making this system useful for production and purification of fully processed Ras and Ras-related proteins. Similar to Rapl purified from human neutrophils, the baculovirus-expressed protein served as a substrate for cyclic AMP-dependent protein kinase in vitro, being phosphorylated with a stoichiometry of approximately one phosphate molecule per molecule of GTP-yS bound (data
El. VOL. 10, 1990 not shown). Therefore, insect cell-produced RaplA appears to be physically homologous to human cell-derived protein and capable of undergoing similar posttranslational modifications in vivo and in vitro.
Before using the recombinant RaplA proteins in biochemical and biological assays, it was important to compare the intrinsic properties of these proteins with those of mammalian Rapl. The guanine nucleotide-binding properties of WT RaplA were similar to those of recombinant Ras (14) and Rapl purified from mammalian sources, although some minor differences were observed. Specifically, the affinities for GTP and GDP were 1.5-to 5-fold lower than those observed for neutrophil Rapl (Table 1) ; however, the Kd value obtained for GTPyS binding to baculovirus-expressed RaplA in Mg2" was similar to that reported for Rapl purified from several mammalian sources (19, 30; Table 1 ). As observed for Ras and neutrophil Rapl (14; G.M.B. and L.A.Q., in press) without Mg2", the affinity of RaplA for GTP was higher than that for GDP. Hall and Self (14) proposed that the rapid off rate of GDP from Ras and the higher affinity of the protein for GTP than for GDP at very low Mg2" levels in vitro could be similar to that which occurs in vivo in response to a cell surface receptor-nucleotide exchange factor. This may also be true for the Rapl protein. Since no release of [a-32P]GTP was stimulated by neutrophil cytosol, such a factor is apparently not abundant in this fraction of the cell.
Although we cloned the raplA gene from a human granulocytic cell library (37), we are unable to exclude the possibility that the Rapl protein purified from human neutrophils is partially or wholly RaplB (which is 95% homologous to RaplA; 35) by N-terminal sequencing or crossreactivity with R52-1 and R64-1 antisera. Thus, the minor differences between the properties of recombinant and neutrophil Rapl proteins could be due to incorrect folding or posttranslational modification of the recombinant protein or differences between RaplA and RaplB. This latter explanation is suggested by the fact that smg-p21 purified from bovine brain and human platelets, which has biochemical properties similar to those of neutrophil Rapl, has recently been shown to be RaplB (26) .
We observed that 35A RaplA had a decreased affinity for (20) , but it has not been demonstrated whether Rapl can respond to Ras-GAP, as suggested by the shared effector domains. Our results demonstrate that even at concentrations much higher than those required to stimulate Ras, Ras-GAP cannot modulate the GTPase activity of Rapl.
Since Rapl does not respond to Ras-GAP and Takai and co-workers (20, 49) have demonstrated that Ras GTPase activity is not stimulated by Rap-GAP(s), the primary sequence of residues 30 to 44 must not be sufficient to enable bound GAPs to stimulate the GTPase activity of Ras proteins. By using a ras-rap chimera, we have shown that the transforming activity of ras resides in the N-terminal half of the protein (J. E. Buss et al., submitted for publication). The regions flanking the putative effector-binding site of Ras and Rap that are unique to these proteins and are the regions of most divergence in the N termini of Ras and Rap could provide the specificity for GAPs to modulate the GTPase activities through the region of residues 30 to 40. This is consistent with the observation that a peptide corresponding to amino acid residues 17 to 32 of Ras can reduce RasRas-GAP interaction (40) . However, it has also recently been shown that purified Ras-GAP stimulates the GTPase activity of the R-ras gene product, the sequence of which diverges from H-Ras, K-Ras, and N-Ras in the regions flanking the putative effector domain (48) . Thus, it seems more likely that the secondary structure of the effector region, alone or in conjunction with unique sites more distant in the primary structure (such as the region encompassing residue 61), dictates whether there is a productive interaction between these Ras-related proteins and their respective GAPs. 
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